Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2007 1
2009 3
2010 2
2011 8
2012 7
2013 3
2014 4
2015 6
2016 9
2017 15
2018 17
2019 17
2020 18
2021 10
2022 4
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 21559978

102 results

Results by year

Filters applied: . Clear all
Page 1
Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs).
Sowa-Staszczak A, Pach D, Chrzan R, Trofimiuk M, Stefańska A, Tomaszuk M, Kołodziej M, Mikołajczak R, Pawlak D, Hubalewska-Dydejczyk A. Sowa-Staszczak A, et al. Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1669-74. doi: 10.1007/s00259-011-1835-8. Epub 2011 May 11. Eur J Nucl Med Mol Imaging. 2011. PMID: 21559978 Free PMC article. Clinical Trial.
Repeated cycles of peptide receptor radionuclide therapy (PRRT)--results and side-effects of the radioisotope 90Y-DOTA TATE, 177Lu-DOTA TATE or 90Y/177Lu-DOTA TATE therapy in patients with disseminated NET.
Pach D, Sowa-Staszczak A, Kunikowska J, Królicki L, Trofimiuk M, Stefańska A, Tomaszuk M, Głowa B, Mikołajczak R, Pawlak D, Jabrocka-Hybel A, Hubalewska-Dydejczyk AB. Pach D, et al. Radiother Oncol. 2012 Jan;102(1):45-50. doi: 10.1016/j.radonc.2011.08.006. Epub 2011 Aug 30. Radiother Oncol. 2012. PMID: 21885142
Can treatment using radiolabelled somatostatin analogue increase the survival rate in patients with non-functioning neuroendocrine pancreatic tumours?
Sowa-Staszczak A, Pach D, Stefańska A, Tomaszuk M, Lenda-Tracz W, Mikołajczak R, Pawlak D, Chrzan R, Gilis-Januszewska A, Przybylik-Mazurek E, Hubalewska-Dydejczyk A. Sowa-Staszczak A, et al. Nucl Med Rev Cent East Eur. 2011;14(2):73-8. doi: 10.5603/nmr.2011.00019. Nucl Med Rev Cent East Eur. 2011. PMID: 22219146 Free article.
102 results